Home LiteratureArticle Details
PMID: 18202132 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Review

Mitochondrial energetics and insulin resistance.

Endocrinology ·Vol. 149 ·No. 3 ·2008-03-00 ·Pages 950-4

Civitarese AE, Ravussin E

Abstract

Obesity, insulin resistance, type 2 diabetes mellitus, and aging are associated with impaired skeletal muscle oxidation capacity, reduced mitochondrial content, and lower rates of oxidative phosphorylation. Several studies have reported ultrastructural abnormalities in mitochondrial morphology and reductions in mitochondrial mass in insulin-resistant individuals. From lower organisms to rodents, mitochondrial membrane structure, function, and programmed cell death are regulated in part by the balance between the opposing forces of mitochondrial fusion and fission, suggesting they may also play an important role in human physiology.

MeSH Terms
Animals Energy Metabolism/physiology Homeostasis/physiology Humans Insulin Resistance/physiology Metalloproteases/physiology Mitochondria, Muscle/physiology Mitochondrial Proteins/physiology
Chemicals
Mitochondrial Proteins Metalloproteases PARL protein, human
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Civitarese Anthony E
Skeletal Muscle Metabolism Laboratory, Human Physiology, Pennington Biomedical Research Center, 6400 Perkins Road, Baton Rouge, Louisiana 70808, USA. CivitaAE@pbrc.edu
Ravussin Eric
References (57)
57 references, click to expand
  1. Human cells are protected from mitochondrial dysfunction by complementation of DNA products in fused mitochondria.
    Nat Genet. 2001 Jul;28(3):272-5 PMID: 11431699
  2. A human dynamin-related protein controls the distribution of mitochondria.
    J Cell Biol. 1998 Oct 19;143(2):351-8 PMID: 9786947
  3. Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling.
    Cell. 2006 Jul 14;126(1):163-75 PMID: 16839884
  4. PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis.
    PLoS Biol. 2005 Apr;3(4):e101 PMID: 15760270
  5. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes.
    Nat Genet. 2003 Jul;34(3):267-73 PMID: 12808457
  6. Peroxisome proliferator-activated receptor-gamma co-activator 1alpha-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency.
    J Biol Chem. 2005 Sep 30;280(39):33588-98 PMID: 16079133
  7. Respiration and phosphorylation of mitochondria isolated from the skeletal muscle of diabetic and normal subjects.
    Diabetologia. 1967 Jun;3(3):346-52 PMID: 4244686
  8. Levels of human Fis1 at the mitochondrial outer membrane regulate mitochondrial morphology.
    J Cell Sci. 2004 Mar 1;117(Pt 7):1201-10 PMID: 14996942
  9. PGC-1beta controls mitochondrial metabolism to modulate circadian activity, adaptive thermogenesis, and hepatic steatosis.
    Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):5223-8 PMID: 17360356
  10. Role of adiponectin in human skeletal muscle bioenergetics.
    Cell Metab. 2006 Jul;4(1):75-87 PMID: 16814734
  11. Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ.
    Am J Physiol. 1990 Nov;259(5 Pt 1):E650-7 PMID: 2240203
  12. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes.
    Diabetes. 2002 Oct;51(10):2944-50 PMID: 12351431
  13. Global and societal implications of the diabetes epidemic.
    Nature. 2001 Dec 13;414(6865):782-7 PMID: 11742409
  14. Abnormal glucose homeostasis in skeletal muscle-specific PGC-1alpha knockout mice reveals skeletal muscle-pancreatic beta cell crosstalk.
    J Clin Invest. 2007 Nov;117(11):3463-74 PMID: 17932564
  15. Fuel selection in human skeletal muscle in insulin resistance: a reexamination.
    Diabetes. 2000 May;49(5):677-83 PMID: 10905472
  16. Mitochondrial morphology and distribution in mammalian cells.
    Biol Chem. 2006 Dec;387(12):1551-8 PMID: 17132100
  17. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents.
    Ann Intern Med. 1990 Dec 15;113(12):909-15 PMID: 2240915
  18. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1.
    Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8466-71 PMID: 12832613
  19. Ceramide content is increased in skeletal muscle from obese insulin-resistant humans.
    Diabetes. 2004 Jan;53(1):25-31 PMID: 14693694
  20. Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM.
    J Appl Physiol (1985). 1997 Jul;83(1):166-71 PMID: 9216960
  21. The mitochondrial rhomboid protease PSARL is a new candidate gene for type 2 diabetes.
    Diabetologia. 2005 Mar;48(3):459-68 PMID: 15729572
  22. Processing of Mgm1 by the rhomboid-type protease Pcp1 is required for maintenance of mitochondrial morphology and of mitochondrial DNA.
    J Biol Chem. 2003 Jul 25;278(30):27781-8 PMID: 12707284
  23. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1.
    Cell. 1999 Jul 9;98(1):115-24 PMID: 10412986
  24. Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents.
    J Clin Invest. 2005 Dec;115(12):3587-93 PMID: 16284649
  25. Mitochondria in steatohepatitis.
    Semin Liver Dis. 2001;21(1):57-69 PMID: 11296697
  26. Control of mitochondrial morphology by a human mitofusin.
    J Cell Sci. 2001 Mar;114(Pt 5):867-74 PMID: 11181170
  27. Mitochondrial function, fibre types and ageing: new insights from human muscle in vivo.
    Exp Physiol. 2007 Mar;92(2):333-9 PMID: 17170059
  28. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss.
    Am J Physiol. 1999 Dec;277(6):E1130-41 PMID: 10600804
  29. Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1alpha and 1beta (PGC-1alpha and PGC-1beta) in muscle cells.
    J Biol Chem. 2003 Jul 18;278(29):26597-603 PMID: 12734177
  30. What if Minkowski had been ageusic? An alternative angle on diabetes.
    Science. 1992 Oct 30;258(5083):766-70 PMID: 1439783
  31. OPA1 requires mitofusin 1 to promote mitochondrial fusion.
    Proc Natl Acad Sci U S A. 2004 Nov 9;101(45):15927-32 PMID: 15509649
  32. Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice.
    Cell. 2004 Oct 1;119(1):121-35 PMID: 15454086
  33. Mitochondrial dysfunction in the elderly: possible role in insulin resistance.
    Science. 2003 May 16;300(5622):1140-2 PMID: 12750520
  34. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes.
    Diabetes. 2002 Jan;51(1):7-18 PMID: 11756317
  35. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat.
    Diabetes. 1997 Oct;46(10):1579-85 PMID: 9313753
  36. A cut short to death: Parl and Opa1 in the regulation of mitochondrial morphology and apoptosis.
    Cell Death Differ. 2007 Jul;14(7):1275-84 PMID: 17464328
  37. Family history of diabetes links impaired substrate switching and reduced mitochondrial content in skeletal muscle.
    Diabetes. 2007 Mar;56(3):720-7 PMID: 17327442
  38. Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance.
    Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17075-80 PMID: 17940018
  39. Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients.
    Diabetes. 2007 May;56(5):1376-81 PMID: 17287462
  40. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator.
    Endocr Rev. 2003 Feb;24(1):78-90 PMID: 12588810
  41. The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses.
    Cell. 2004 Dec 17;119(6):873-87 PMID: 15607982
  42. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes.
    N Engl J Med. 2004 Feb 12;350(7):664-71 PMID: 14960743
  43. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1.
    Nature. 2005 Mar 3;434(7029):113-8 PMID: 15744310
  44. Cells lacking Pcp1p/Ugo2p, a rhomboid-like protease required for Mgm1p processing, lose mtDNA and mitochondrial structure in a Dnm1p-dependent manner, but remain competent for mitochondrial fusion.
    Biochem Biophys Res Commun. 2003 Aug 22;308(2):276-83 PMID: 12901865
  45. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians.
    N Engl J Med. 1993 Dec 30;329(27):1988-92 PMID: 8247074
  46. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators.
    Cell. 2006 Oct 20;127(2):397-408 PMID: 17055439
  47. Mitochondrial GTP regulates glucose-stimulated insulin secretion.
    Cell Metab. 2007 Apr;5(4):253-64 PMID: 17403370
  48. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle.
    J Biol Chem. 2002 Dec 27;277(52):50230-6 PMID: 12006582
  49. Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents.
    PLoS Med. 2005 Sep;2(9):e233 PMID: 16089501
  50. Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss.
    FASEB J. 1999 Nov;13(14):2051-60 PMID: 10544188
  51. Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy.
    Ann Neurol. 2004 Nov;56(5):719-23 PMID: 15505825
  52. Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes.
    Arch Biochem Biophys. 2003 Nov 15;419(2):101-9 PMID: 14592453
  53. Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes.
    PLoS Med. 2007 May;4(5):e154 PMID: 17472434
  54. Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity.
    J Biol Chem. 2003 May 9;278(19):17190-7 PMID: 12598526
  55. Mitochondrial reticulum in limb skeletal muscle.
    Am J Physiol. 1986 Sep;251(3 Pt 1):C395-402 PMID: 3752235
  56. The axonal transport of mitochondria.
    J Cell Sci. 2005 Dec 1;118(Pt 23):5411-9 PMID: 16306220
  57. Mitochondrial membrane remodelling regulated by a conserved rhomboid protease.
    Nature. 2003 May 29;423(6939):537-41 PMID: 12774122
Article Info
Journal
Endocrinology
Abbr.
Endocrinology
ISSN
0013-7227
Published
2008-03-00
Epub
2008-00-17
Pages
950-4
Language
English
Region
United States
NLM ID
0375040
PMCID
PMC2275359
Subset
IM
Grants
NIDDK NIH HHS · P30 DK072476 · United States
NIA NIH HHS · U01 AG020478 · United States
NIA NIH HHS · R01 AG20478 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com